Average Co-Inventor Count = 2.7

ph-index = 5

Forward Citations = 119(Granted Patents)

Location History:

Needham, MA (US) (1987 - 2001)
Brookline, MA (US) (2001)
Tokyo, JP (2007 - 2022)

Company Filing History:

8 out of 1,206

Dana-farber-cancer Institute Inc.

patents

2 out of 5,444

University of Texas System

The University of Tokyo

where one patent can have more than one assignee

Years Active: 1987-2022

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11273217 - Cancer treatment composition combining anti-CD26 antibody and other anticancer agent (2022-03-15),

2. 8771688 - Method of treating malignant mesothelioma (2014-07-08),

3. 7704686 - Methods of identifying immunoregulatory agents, immunoregulatory agents, and uses thereof (2010-04-27),

4. 7658923 - Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26 (2010-02-09),

5. 7198788 - Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26. (2007-04-03),

6. 6325989 - Form of dipeptidylpeptidase IV (CD26) found in human serum (2001-12-04),

7. 6265551 - Form of dipeptidylpeptidase IV (CD26) found in human serum, antibodies thereto, and uses thereof (2001-07-24),

8. 5120642 - Monoclonal antibody which distinguishes helper inducer and suppressor (1992-06-09),

9. 5002869 - Monoclonal antibody specific to a novel epitope of the LFA-1 antigen of (1991-03-26),

10. 4882424 - Activation antigen (1989-11-21),

11. 4661446 - Monoclonal antibodies and method of immunizing therewith (1987-04-28),

12. 4649106 - Distinguishing subsets of human cells (1987-03-10),

Title: The Innovative Contributions of Inventor Chikao Morimoto

Introduction

Chikao Morimoto is a renowned inventor based in Needham, MA, who has made significant strides in the field of cancer treatment. With a total of 12 patents to his name, Morimoto's work focuses on advancing therapeutic solutions for malignant mesothelioma, a challenging type of cancer.

Latest Patents

Morimoto's latest patents underscore his innovative approach to cancer therapy. One notable invention involves a cancer treatment composition that combines an anti-CD26 antibody with other anticancer agents to enhance the efficacy of standard treatments. His research indicates that the growth inhibitory effect of standard cisplatin-pemetrexed therapy is potentiated when combined with an anti-CD26 antibody. Additionally, Morimoto has developed a novel antibody-drug conjugate, Y-TR1, which is exceptionally effective against CD26-positive malignant mesothelioma cells. Another significant patent outlines a method for treating malignant mesothelioma using substances that inhibit the binding of CD26 to the extracellular matrix, employing innovative techniques such as siRNA targeting and the use of anti-CD26 antibodies.

Career Highlights

Throughout his career, Chikao Morimoto has worked at prestigious institutions, including the Dana-Farber Cancer Institute and the University of Texas System. His role in these organizations has allowed him to contribute extensively to cancer research and develop groundbreaking therapies that hold promise for patients battling mesothelioma.

Collaborations

Morimoto's work has been enriched through collaborations with esteemed colleagues, including Stuart F. Schlossman and Jonathan S. Duke-Cohan. These professional partnerships have fostered a creative environment where innovative ideas can flourish, leading to advancements in therapeutic strategies for cancer treatment.

Conclusion

Chikao Morimoto's contributions to the field of cancer treatment through his patents and innovative research demonstrate his commitment to improving patient outcomes. His groundbreaking work not only showcases his inventive spirit but also holds the potential to significantly impact the availability of effective therapies for malignant mesothelioma and beyond.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.